PAR 2.04% 24.0¢ paradigm biopharmaceuticals limited..

Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-66

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    The difficulty is in justifying use of PPS as a prophylactic. I'd assume there will be little justification to use it as a prophylactic for hayfever, while it might be more difficult to use a prophylactic in asthma since asthma is generally permanent following diagnosis. There might be justification to use it in high risk settings.

    While COVID is picked up earlier in patients who are tested daily, it still takes a few days for the virus to establish itself in its host before it becomes detectable.

    Based on today's results, I definitely think it'll be a good idea to look at PPS in the acute heart disease setting. I know a lot about acute myocardial infarction and the role inflammation plays and its definitely something I would look at if I were PAR.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.005(2.04%)
Mkt cap ! $83.98M
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $202.2K 814.1K

Buyers (Bids)

No. Vol. Price($)
5 181098 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 118621 5
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.